Immunocore Holdings plc
IMCR
$27.96
-$0.57-1.98%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 2.10% | 0.76% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.10% | 0.76% | |||
| Cost of Revenue | 100.24% | -359.65% | |||
| Gross Profit | -63.24% | 786.43% | |||
| SG&A Expenses | -11.24% | 7.20% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.83% | -5.79% | |||
| Operating Income | 19,575.68% | 100.52% | |||
| Income Before Tax | 184.03% | -5,295.39% | |||
| Income Tax Expenses | -97.89% | 2,865.90% | |||
| Earnings from Continuing Operations | 143.15% | -16,883.05% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 143.15% | -16,883.05% | |||
| EBIT | 19,575.68% | 100.52% | |||
| EBITDA | 844.66% | 113.67% | |||
| EPS Basic | 142.91% | -16,920.00% | |||
| Normalized Basic EPS | 172.39% | -5,247.37% | |||
| EPS Diluted | 141.97% | -16,920.00% | |||
| Normalized Diluted EPS | 169.38% | -5,247.37% | |||
| Average Basic Shares Outstanding | 0.57% | 0.12% | |||
| Average Diluted Shares Outstanding | 4.89% | 0.12% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||